Cardinal Health gets RBC Buy, $276 target on Nuclear Medicine
RBC Capital Markets initiates Cardinal Health with a buy rating and a $276 price target, citing the company’s Nuclear Medicine business and its expected profit contribution.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.